<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04539067</url>
  </required_header>
  <id_info>
    <org_study_id>635_5/2020</org_study_id>
    <nct_id>NCT04539067</nct_id>
  </id_info>
  <brief_title>Effect of Controlled Ovarian Stimulation in Quality of Oocyte and Embryo</brief_title>
  <official_title>Effect of Controlled Ovarian Stimulation With H FSH and HHMg Vs HMG Alone on Oocyte and Embryo Quality in IcsI Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Minia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Minia University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigate and compare the efficacy of H FSH plus HMG Vs HMG alone on oocyte and embryo&#xD;
      quality in IcsI patients&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      70 patients divided in to 2groups Group A controlled ovarian stimulation with H FSH and HHMg&#xD;
      Group B controlled ovarian stimulation with HMG alone Results will be discussed later&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2020</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">September 2021</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison between the efficacy of controlled ovarian stimulation with H FSH plus HMG Vs HmG alone on oocyte and embryo quality in IcsI patients</measure>
    <time_frame>9 months</time_frame>
    <description>Comparison between the efficacy of controlled ovarian stimulation with H FSH plus HMG Vs HmG alone on oocyte and embryo quality in IcsI patients</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Ovarian Stimulation</condition>
  <arm_group>
    <arm_group_label>HMG group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Induction of ovulation from 2nd day of cycle Follow diameter of follicle When follicle 18:22mm Receive HMG</description>
  </arm_group>
  <arm_group>
    <arm_group_label>H FSH plus HHMG</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Follow up ovulation from the 2nd day to 5th of menstruation cycle When follicle diameter 18mm to 22mm made induction of ovulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>HHMG</intervention_name>
    <description>Induction of ovulation from the 2nd day of cycle to 5th day then follow the diameter of follicle Use transvaginal ultrasound When diameter of follicle 18 to 22 patients receiving HMG</description>
    <arm_group_label>H FSH plus HHMG</arm_group_label>
    <arm_group_label>HMG group</arm_group_label>
    <other_name>Using HHMG for induction</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Infertil women aged from 20_35yr&#xD;
&#xD;
          2. Normal utreus&#xD;
&#xD;
          3. Normal ovaries&#xD;
&#xD;
          4. unexplained infertility&#xD;
&#xD;
          5. no endometriosis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        1 - poor responders to gonadotropin 2-Prior history of more than 3unsucceful ICSI 3-Any&#xD;
        malformation of sexual organs&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marwa Ba Tarahony</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of Medicine, Minia University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marwa Ba Tarahony</last_name>
    <phone>01008160037</phone>
    <email>marwatarahony9@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kareem Ib Shaheen</last_name>
    <phone>01210966045</phone>
  </overall_contact_backup>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 25, 2020</study_first_submitted>
  <study_first_submitted_qc>August 31, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 4, 2020</study_first_posted>
  <last_update_submitted>August 31, 2020</last_update_submitted>
  <last_update_submitted_qc>August 31, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Minia University</investigator_affiliation>
    <investigator_full_name>Marwa Bahgat Tarahony</investigator_full_name>
    <investigator_title>Eygpt Minia</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

